The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies
ConclusionThe decision to utilize CRS-HIPEC should involve a multidisciplinary team approach and evaluation of prognostic factors to balance the short-term morbidity of the operation with maximum long-term benefits. Large, multi-institutional groups and ongoing trials hold promise for clarifying the role of CRS-HIPEC in peritoneal surface malignancies.
Source: Journal of Gastrointestinal Surgery - Category: Surgery Source Type: research
More News: Asbestosis | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Colorectal Cancer | Gastric (Stomach) Cancer | Gastroenterology | Mesothelioma | Ovarian Cancer | Ovaries | Perfusion | Peritoneal Cancer | Sarcomas | Study | Surgery